Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
A Worldwide Index Funds Portfolio combines global equity exposure with low fees and broad diversification, helping you track major markets and simplify investing.
20,119 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Solmate plans a reverse stock split to fund a Solana-focused hub in the UAE, part of a broader pivot that includes ex...
Flotek's 2025 earnings outlook hinges on energy demand, cost control, and segment mix. This guide breaks down what to...
Gold miners and royalty firms are drawing attention as uncertainty lingers and rates shift. This report breaks down t...
Versant Media Group launches a CNBC-based direct-to-consumer platform for retail investors, pairing journalism with A...
Volatility in tech stocks has investors watching Micron Technology (MU) closely. This guide breaks down why MU could ...
In 2026, a disciplined trio of growth ETFs offers a clear path to long-term wealth through earnings-driven expansion,...
A fresh study links Gen Z’s straight‑A trend to lower long‑term earnings, signaling hidden costs behind perfect repor...
When you hear an insider just sold 10,000 shares, it triggers questions. This guide explains how to interpret such mo...
SoFi's Galileo platform powers card programs and payments for fintech partners. This article explains why sofi's gali...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...